AML-712: Revumenib + Intensive Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia Harboring Genetic Alterations in KMT2A, NPM1, or NUP98: Updated Phase 1 Results From SNDX-5613-0708

Poster Presentation | Sep 9, 2026

Author

Aldoss I, et al.

Congress

Society of Hematologic Oncology (SOHO) 14th Annual Meeting

Houston, Texas | Sep 9 – 12, 2026